Platinum Management’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,143
Closed -$56K 7
2014
Q4
$56K Hold
2,143
0.12% 31
2014
Q3
$232K Buy
+2,143
New +$279K 0.05% 98

Other funds holding ARCT

Platinum Management's ARCT Position: Q1 2015 in Review

Platinum Management sold out of Arcturus Therapeutics (ARCT) in Q1 2015, closing a stake of 2,143 shares — an estimated $56K sold.

Platinum Management first reported a position in ARCT in Q3 2014 and held it in 2 quarters. The position peaked at $232K in Q3 2014. 28 funds tracked by Wall St. Rank hold ARCT as of Q1 2015.

  • Platinum Management reported no remaining Arcturus Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Platinum Management sold 2,143 Arcturus Therapeutics shares in Q1 2015, an estimated $56K.
  • Platinum Management first reported a position in Arcturus Therapeutics in Q3 2014 and held it in 2 quarters.
  • Platinum Management's Arcturus Therapeutics position peaked at $232K in Q3 2014.
  • 28 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2015.

Based on Platinum Management's 13F filing for Q1 2015, filed 15 May 2015.